Hello from Toronto

psquared2

Junior Member

Join Date: Aug 2009

Posts: 1
- Share
- Tweet
#1

Hello from Toronto

08-10-2009, 06:04 AM

My name is David, a MSc. (York) working in a bioinformatics lab in University of Toronto (for the summer!)

I am working with Illumina/Solexa dataset and while I am fascinated/amazed by what next-gen sequencing can do, I am frustrated by my datasets not cooperating with the analysis at the moment. I'll be browsin' through the forums to see whether others have done for the similar problem.
Tags: None
aguffanti

Member

Join Date: Dec 2008

Posts: 29
- Share
- Tweet
#2

08-10-2009, 08:27 AM

Hello from Milano, Italy

Hello everyone. I am Alessandro and I am working on SOLiD data analysis, I work nearby Milano (Italy) in a company called Genomnia. I have also a long previous experience with 454 sequence data analysis.

Keep in touch and ciao,

Alessandro
Comment

Previous template Next

Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications

by SEQadmin2

Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

The systematic characterization of the human proteome has...
- Channel: Articles
07-20-2026, 11:48 AM
Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems

by SEQadmin2

Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...
- Channel: Articles
07-09-2026, 11:10 AM
Cancer Drug Resistance: The Lingering Barrier to Rising Survival

by SEQadmin2

Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
- Channel: Articles
07-08-2026, 05:17 AM

Topics	Statistics	Last Post
Study Captures the First Moments of DNA Replication by SEQadmin2 Started by SEQadmin2, 07-24-2026, 12:17 PM	0 responses 26 views 0 reactions	Last Post by SEQadmin2 07-24-2026, 12:17 PM
Chemotherapy Leaves Detectable DNA Signatures in Childhood Tumors by SEQadmin2 Started by SEQadmin2, 07-23-2026, 11:41 AM	0 responses 21 views 0 reactions	Last Post by SEQadmin2 07-23-2026, 11:41 AM
Single-Cell Atlases Skew Toward European Ancestry, Analysis Finds by SEQadmin2 Started by SEQadmin2, 07-20-2026, 11:10 AM	0 responses 210 views 0 reactions	Last Post by SEQadmin2 07-20-2026, 11:10 AM
UC San Diego Bioengineers Map Gene Function in Human Stem Cells by SEQadmin2 Started by SEQadmin2, 07-13-2026, 10:26 AM	0 responses 78 views 0 reactions	Last Post by SEQadmin2 07-13-2026, 10:26 AM

Unconfigured Ad

Comment

Latest Articles

ad_right_rmr

News